Rilzabrutinib (Wayrilz; Sanofi), a BTK inhibitor, targets immune-mediated platelet destruction in immune thrombocytopenia (ITP) and has demonstrated a favorable safety profile.
Everyday Health on MSN
We tested over 65 online therapy companies — these 11 were the most affordable we actually would recommend
After testing over 65 therapy services to find the best options, we believe these 11 most affordable online therapy services ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback